Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

已完结 20 由达姆发布于 2026/9/9 9:20:52

DOI:10.1182/blood.2025031704
作者：Lucas Kühne,?Thomas Osterholt,?Maximilian Suer,?Sadrija Cukoski,?Ralph Wendt,?Christian Pfrepper,?Sirak Petros,?Ulf Sch?nermarck,?Anke von Bergwelt-Baildon,?Jessica Kaufeld,?Anja G?ckler,?Kristina Sc
文献类型：期刊论文
补充材料：只需要正文

American Society of Hematology (ASH)

Abstract：Abstract: Immune thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening condition. Caplacizumab substantially shortens the time to clinical response, yet delayed platelet cou

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Gaussian 09 (Revision D.01).